Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+4.9%
5Y CAGR+20.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.9%/yr
vs +98.2%/yr prior
5Y CAGR
+20.9%/yr
Recent deceleration
Acceleration
-93.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $351.60M | +15.0% |
| 2024 | $305.81M | +3.4% |
| 2023 | $295.72M | -2.9% |
| 2022 | $304.56M | +48.0% |
| 2021 | $205.77M | +51.1% |
| 2020 | $136.19M | +217.2% |
| 2019 | $42.94M | +117.6% |
| 2018 | $19.73M | +380.6% |
| 2017 | $4.11M | - |